Medicxi Bolsters and Expands Team with Senior Industry Leaders Mar 17, 2020 04:00AM
Divide & Conquer, Developing New Class of Cancer Therapeutics to Disrupt Cell-to-Cell Communication, Emerges from Stealth as New Paper by Co-Founder is Published in Nature Sep 18, 2019 01:00PM
Medicxi Closes a New €400m Fund (Medicxi III) to Power the Next Wave of Biopharma Entrepreneurs and Drug Hunters Jul 18, 2019 07:00PM